5th Circ. Quashes Generic Reglan Failure-To-Warn Suit
A three-judge panel said Pliva Inc., Teva Pharmaceuticals USA Inc. and Purepac Pharmaceutical Co. are saved by the U.S. Supreme Court's decision in Pliva Inc. v. Mensing because the generic companies are dependent on brand names taking the lead when it comes to warnings.
Appellants Penny and John...
To view the full article, register now.